Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun 6;17(6):6916-29.
doi: 10.3390/molecules17066916.

Potent anti-HIV activities and mechanisms of action of a pine cone extract from Pinus yunnanensis

Affiliations

Potent anti-HIV activities and mechanisms of action of a pine cone extract from Pinus yunnanensis

Xuan Zhang et al. Molecules. .

Abstract

The anti-HIV activities of a pine cone extract (YNS-PY-F) from Pinus yunnanensis have been evaluated, and its mechanisms of action were also explored. The pine cone extract, YNS-PY-F, potently inhibited HIV-1(IIIB), HIV-1(RF), HIV-1(A17), HIV-1(AO18) and HIV-2(ROD) and induced cytopathic effect in C8166 cells with EC₅₀ values of 0.96 μg/mL, 1.53 μg/mL, 0.88 μg/mL, 7.20 μg/mL and 6.17 μg/mL, respectively. The quantification of a p24 production assay showed that YNS-PY-F significantly inhibited the acute replication of HIV-1(IIIB), HIV-1RF, HIV-1(A17) and HIV-1(AO18) in C8166 cells. An MTT assay showed that YNS-PY-F also significantly inhibited the HIV-1(IIIB) induced cytolysis in MT-4 cells with an EC₅₀ value of 2.22 μg/mL. The mechanism assays showed that YNS-PY-F had potent inhibitory effects on the fusion between infected cells and uninfected cells, and the activity of HIV-1 reverse transcriptase, with EC₅₀ values of 7.60 μg/mL and 4.60 μg/mL, respectively. Overall, these data suggest that the pine cone extract from Pinus yunnanensis has potent inhibitory activities against HIV-1(IIIB), HIV-1(RF), RT inhibitor-resistant strains HIV-1(A17) and HIV-1(AO18), and HIV-2(ROD), and its anti-HIV mechanisms include inhibition of HIV entry and inhibition of reverse transcriptase activity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cytotoxities and anti-HIV activities of YNS-PY-F. Cytotoxities on C8166 and MT-4 cells were measured by MTT assay (A); Inhibitory activities on HIV-1IIIB, HIV-1RF, HIV-1A17, HIV-1AO18 and HIV-2ROD in C8166 cells were measured by syncytia reduction assay (B); Inhibitory activities on acute replication of HIV-1IIIB, HIV-1RF, HIV-1A17 and HIV-1AO18 in C8166 cells were measured by quantification of p24 antigen production (C); Inhibitory activity on HIV-1IIIB induced cytolysis in MT-4 cells was measured by MTT assay (D). The data shown in the figure are a representative of at least two independent experiments.
Figure 2
Figure 2
Inhibitory effects of YNS-PY-F on cell-to-cell fusion and RT activity. Inhibitory activity on the fusion of uninfected C8166 cells and H9 cells chronically infected HIV-1IIIB was measured by syncytia reduction assay (A); Inhibitory activity on recombinant HIV-1 reverse transcriptase was measured by ELISA assay (B). The data shown in the figure are a representative of at least two independent experiments.
Figure 3
Figure 3
Effect of YNS-PY-F on the nuclear import of HIV-1 integrase in HeLa cells. (A) Negative control: EGFP-IN mainly distributed in the nucleus of HeLa cells; (B) D77 at 100 μg/mL: EGFP-IN mainly distributed in the cytoplasm of HeLa cells; (C) YNS-PY-F at 200 μg/mL: EGFP-IN mainly distributed in the nucleus of HeLa cells. The scale bar was 25 μm.
Figure 4
Figure 4
Effect of YNS-PY-F on SDF-1α induced CXCR4 internalization. (A) Negative control: EGFP-CXCR4 mainly distributed in the cytoplasm of 293 T cells treated by SDF-1α; (B) AMD3100 at 10 μM: EGFP-CXCR4 still mainly distributed in the cell membrane of cells treated by SDF-1α and AMD3100; (C) YNS-PY-F at 200 μg/mL: EGFP-CXCR4 mainly distributed in the cytoplasm of 293 T cells treated by SDF-1α andYNS-PY-F. The scale bar was 25 μm.
Figure 5
Figure 5
The structure of lignin-carbohydrate complex [16]. Carbohydrate represents polysaccharide portion of lignin–carbohydrate complex.

Similar articles

Cited by

References

    1. Adamson C.S., Freed E.O. Novel approaches to inhibiting HIV-1 replication. Antiviral Res. 2010;85:119–141. doi: 10.1016/j.antiviral.2009.09.009. - DOI - PMC - PubMed
    1. Cos P., Maes L., Vanden Berghe D., Hermans N., Pieters L., Vlietinck A. Plant substances as anti-HIV agents selected according to their putative mechanism of action. J. Nat. Prod. 2004;67:284–293. doi: 10.1021/np034016p. - DOI - PubMed
    1. de Clercq E. Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Med. Res. Rev. 2000;20:323–349. doi: 10.1002/1098-1128(200009)20:5<323::AID-MED1>3.0.CO;2-A. - DOI - PubMed
    1. Zhang X., Huang N., Zheng Y.T. Advances in the study of anti-HIV natural compounds derived from traditional Chinese medicines (in Chinese) Acta Pharm. Sin. 2010;45:141–153. - PubMed
    1. Sakagami H., Kawazoe Y., Komatsu N., Simpson A., Nonoyama M., Konno K., Yoshida T., Kuroiwa Y., Tanuma S. Antitumor, antiviral and immunopotentiating activities of pine cone extracts: Potential medicinal efficacy of natural and synthetic lignin-related materials (review) Anticancer Res. 1991;11:881–888. - PubMed

Publication types